InsiderTrades.com logo
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

FLC Insider Trading

Insider Ownership Percentage: 60.25%
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

Fluence Insider Trading History Chart

This chart shows the insider buying and selling history at Fluence by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Fluence Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for FLC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

Fluence Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/29/2024Thomas (Tom) PokorskyInsiderExpiry1,015,625A$0.17A$172,656.25
12/4/2023Norman AshtonInsiderIssued1,000,000A$0.08A$80,000.00
7/25/2023Samantha ToughInsiderExpiry1,000,000A$0.15A$150,000.00
6/6/2023Paul DonnellyInsiderIssued500,000A$0.11A$54,500.00
5/30/2023Paul DonnellyInsiderExpiry500,000A$0.19A$92,500.00
5/25/2023Rengarajan RameshInsiderExpiry1,250,000A$0.20A$243,750.00
See Full Table
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

SEC Filings (Institutional Ownership Changes) for Fluence (ASX:FLC)

9.96% of Fluence stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Fluence Corporation Limited, together with its subsidiaries, provides water and wastewater treatment solutions for the municipal, commercial, and industrial markets worldwide. The company offers water products, such as decentralized water treatment, NIROBOX desalination water blocks, NIROFLEX smart packaged plants, ultrafiltration, and reverse osmosis systems. It also provides wastewater treatment products, including decentralized wastewater treatment, dissolved air floatation, MABR and SUBRE wastewater treatment, anaerobic digestion, nitro shortcut nitrogen removal, Smart packaged Aspiral and EcoBox, and Tipton series extended aeration WWTPS. In addition, the company offers food and beverage processing and recovery solutions, reuse, desalination, and waste-to-energy solutions. Further, the company provides project finance, Smart Operations data analytics software, and after-sale support services. Fluence Corporation Limited was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Read More on Fluence

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

284,777 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

13.33%

Beta

0.41

Who are the company insiders with the largest holdings of Fluence?

Fluence's top insider investors include:
  1. Norman Ashton (Insider)
  2. Paul Donnelly (Insider)
  3. Rengarajan Ramesh (Insider)
  4. Samantha Tough (Insider)
  5. Thomas (Tom) Pokorsky (Insider)
Learn More about top insider investors at Fluence.
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...